V-Capital is supporting Chinese enterprises with transformation and upgrading by M&a;A or other strategic cooperative methods.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
V-Capital is supporting Chinese enterprises with transformation and upgrading by M&a;A or other strategic cooperative methods, sculpturing the art of investment globally They invest globally based on the demands of our clients. We also deliver strategic advice and solutions to Chinese public corporations, private enterprises, and other institutions.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2020 | Xiaoneng Technology | Series C | 17.6M |
5/2017 | Champion | Series A | 2.9M |
9/2015 | Sichuan Jiuzhou Beidou Daohang Yuweizhi Fuwu Co., Ltd. | Series A | 1.6M |
4/2020 | Cloudbreak Therapeutics | Series B | 0 |
11/2016 | Ubike | Series A | 22.1M |
4/2019 | Sinopharm Online | Series B | 44.6M |
11/2020 | Asieris Pharmaceuticals | Series D | 0 |
1/2019 | Qinhan Hutong | Series A | 14.5M |
6/2022 | Huafu Information | Venture Round | - |
12/2021 | Lineprinting | Series A | 64.5M |
11/2021 | Raydiant Oximetry | Series A | 0 |
12/2019 | ONLY STEM | Series B | - |
5/2017 | Quanyuantang | Post-IPO Equity | 11.8M |
11/2021 | Fogarty Institute of Innovation | Series A | 0 |
2/2022 | Haizhi Wangju Internet Technology | Series D | 0 |
1/2017 | Wanyoo | Series D | 30M |
6/2019 | Huidian Cloud | Series A | 0 |
6/2022 | Huafu Information | Venture Round | - |
2/2022 | Haizhi Wangju Internet Technology | Series D | 0 |
12/2021 | Lineprinting | Series A | 0 |
11/2021 | Fogarty Institute of Innovation | Series A | 0 |
11/2021 | Raydiant Oximetry | Series A | 0 |
11/2020 | Asieris Pharmaceuticals | Series D | 0 |
4/2020 | Cloudbreak Therapeutics | Series B | 0 |
4/2020 | Xiaoneng Technology | Series C | 0 |
12/2019 | ONLY STEM | Series B | - |
6/2019 | Huidian Cloud | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|